Results 11 to 20 of about 3,526 (188)

Resistance to non-depolarizing neuromuscular blocking agents

Asian Pacific Journal of Health Sciences, 2020
The authors experienced three cases of the resistance to the nondepolarizing neuromuscular blocking agents (NMBAs), rocuronium. There are many factors that affect NMBAs such as steroid, endocrine or autoimmune diseases which are thyroid disease, parathyroid disease, myasthenia gravis and etc., and anticonvulsant medication.
Dong-Min Hyun, Young-Mu Kim, Jae-Ho Lee, Jin Sun Kim, Hong Seuk Yang   +4 more
openaire   +3 more sources

Neuromuscular blockade management for intraoperative neural monitoring

Kaohsiung Journal of Medical Sciences, 2020
This article reviews the literature on development of neuromuscular blockade management in thyroid surgery with intraoperative neural monitoring (IONM) in the past decade.
I‐Cheng Lu, Sheng‐Hua Wu, Che‐Wei Wu   +2 more
doaj   +2 more sources

Sugammadex: A neuromuscular blockade agent encapsulator

Southwest Respiratory and Critical Care Chronicles, 2017
Sugammadex sodium, a modified γ-cyclodextrin, represents a new class of drugs effective at reversing non-depolarizing muscle relaxants rocuronium and vecuronium.
Victoria Yepes Hurtado
doaj   +2 more sources

Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs

Acta Veterinaria Scandinavica, 2022
Background: Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under general anaesthesia and postoperative residual ...
Kamilla Pedersen, Linda Loisa Kruhøffer, Jens Lykkesfeldt, Birgitte Saima Kousholt   +3 more
doaj   +2 more sources

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis

Clinical and Translational Science, 2023
Sugammadex, a selective antagonist of steroidal non‐depolarizing neuromuscular blocking agents, has been used in children in limited circumstances. However, neither pharmacokinetics (PKs) nor recovery profile of sugammadex for intense neuromuscular ...
Sang‐Hwan Ji, Ki Young Huh, Jaeseong Oh, Hee‐Jeong Jeong, Young‐Eun Jang, Eun‐Hee Kim, Ji‐Hyun Lee, Jin‐Tae Kim, Hee‐Soo Kim   +8 more
doaj   +2 more sources

Use and Outcomes of Sugammadex for Neurological Examination after Neuromuscular Blockade in the Emergency Department [PDF]

Western Journal of Emergency Medicine
Introduction: Non-depolarizing agents such as rocuronium and vecuronium are frequently used in the emergency department (ED) to facilitate intubation but may lead to delay in neurologic examination and intervention.
Stephen D. Hallisey, Christiana K. Prucnal, Annette M. Ilg, Raghu R. Seethala, Paul S. Jansson   +4 more
doaj   +2 more sources

The use of neuromuscular non-depolarizing blockers and their reversal agents by anesthesiologists Valle del Cauca, Colombia

Colombian Journal of Anesthesiology, 2012
Abstract Objectives To describe the prevalence of use of non-depolarizing neuromuscular blockers/relaxants by anesthesiologists in our area, and the perception of anesthesiologists in the Valle del Cauca region with regards to monitoring. Methodology A descriptive, cross-sectional study including 258 anesthesiologists, and a review of the data ...
Lema Flórez, Eduardo, Tafur, Luis Alberto, Lucía Giraldo, Alba   +2 more
exaly   +2 more sources

The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig.

Acta medica Okayama, 1997
The effect of various non-depolarizing neuromuscular blocking agents (gallamine, pancuronium, vecuronium, d-tubocurarine, metocurine, atracurium and pipecuronium) on [3H]acetylcholine release in the response to field electrical stimulation was investigated in vitro in preparations of the guinea pig right atrium.
Manabe, Nobuki
openaire   +4 more sources

Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations [PDF]

Anesthesia and Pain Medicine, 2023
Due to unknown safety concerns, sugammadex should not be administered to patients with end-stage renal disease (ESRD). However, because the supply of benzylisoquinolinium-type neuromuscular blocking agents (NMBAs) has been discontinued, rocuronium is the
Seok Kyeong Oh, Byung Gun Lim
doaj   +1 more source

A Case of Respiratory Arrest After Lung Cancer Surgery due to Recurarization of Rocuronium Bromide. [PDF]

Respirol Case Rep
An 82‐year‐old male lung cancer patient experienced respiratory arrest after surgery due to recurarization of rocuronium bromide. Considering that many lung cancer patients are elderly and have numerous comorbidities, the risk of recurarization associated with muscle relaxants should always be considered.
Miura H, Miura J, Goto S, Yamamoto T.
europepmc   +2 more sources